ARTIVION, INC. — Director's Dealing 2017

Feb 23, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2017-02-19

Reporting Person: Capps Scott B (VP, Clinical Research)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-02-19	Common Stock	F	1747	$17.25	Disposed	107366	Direct
2017-02-19	Common Stock	A	10471	$17.25	Acquired	109113	Direct
2017-02-19	Common Stock	F	785	$17.25	Disposed	98642	Direct
2017-02-21	Common Stock	A	4444	—	Acquired	111810	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$16.3	2024-02-21	Common Stock (12520)	12520	Direct

Footnotes

F1: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations.

F2: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date.

F3: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company.